Home/Filings/4/0001410384-25-000015
4//SEC Filing

Price Jonathan 4

Accession 0001410384-25-000015

CIK 0001410384other

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 4:24 PM ET

Size

9.0 KB

Accession

0001410384-25-000015

Insider Transaction Report

Form 4
Period: 2025-02-21
Price Jonathan
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2025-02-21$88.82/sh26,130$2,320,867200,114 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2025-02-2111,6410 total
    Exercise: $47.00From: 2019-03-03Exp: 2025-03-08Common Stock (11,641 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-21$47.00/sh+11,641$547,127226,244 total
Footnotes (3)
  • [F1]The sale reported was effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on November 22, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.7355 to $89.3411 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]This option grant vested as to 1/4 of the total option grant on March 3, 2019, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests.

Issuer

Q2 Holdings, Inc.

CIK 0001410384

Entity typeother

Related Parties

1
  • filerCIK 0001806954

Filing Metadata

Form type
4
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:24 PM ET
Size
9.0 KB